ACA adopts clinical practice guidelines for treatment of low back pain

The American Chiropractic Association (ACA), during its annual House of Delegates meeting March 17, approved a resolution to adopt clinical practice guidelines for the treatment of low back pain from the American College of Physicians (ACP) and the Council on Chiropractic Guidelines and Practice Parameters (CCGPP). The association seeks to direct its members, payers and policy makers toward shared interpretations of current evidence-based best practices.

The ACP guideline, "Noninvasive Treatments for Acute, Subacute and Chronic Low Back Pain: A Clinical Practice Guideline from the American College of Physicians," was published Feb. 14 in the Annals of Internal Medicine. The guideline recommends first using non-invasive, non-drug treatments before turning to drug therapies for both acute and chronic low back pain, and further advises that opioids be used only as a last resort.

In conjunction with the ACP guideline, ACA encourages the use of "Clinical Practice Guideline: Chiropractic Care for Low Back Pain," which are chiropractic-specific guidelines from CCGPP that offer guidance in the management or co-management of low-back pain patients within a chiropractic office.

"By identifying and adopting guidelines that ACA believes reflect best practices based on the best available scientific evidence on low back pain, we hope not only to enhance outcomes but also to create greater consensus regarding patient care among chiropractors, payers and policy makers," said ACA President David Herd, DC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Non-viral gene therapy offers hope for chronic low back pain sufferers